Direxion Launches Three Bear ETFs Tracking Popular Indexes

December 4, 2015 by

direxion 600X300Direxion announced today that it has added three new ETFs to its existing lineup of multi-directional ETFs. 

The Direxion Daily S&P Biotech Bear 1X Shares (NYSEARCA:LABS) seeks daily investment results, before fees and expenses, of 100% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The Direxion Daily Healthcare Bear 3X Shares (NYSEARCA:SICK) seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the Health Care Select Sector Index. The Direxion Daily Natural Gas Related Bear 3X Shares (NYSEARCA:GASX) seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the ISE-Revere Natural Gas Index.

Fund

 Symbol

CUSIP

Benchmark

Daily Target

Gross Expense

Ratio

Net Expense Ratio

Direxion Daily S&P Biotech Bear 1X Shares

LABS

 25490K380

S&P Biotechnology Select Industry Index

-100%

0.56%

0.45%

Direxion Daily Healthcare Bear 3X Shares

SICK

 25490K372

Health Care Select Sector Index

-300%

0.96%

0.95%

Daily Natural Gas Related Bear 3X Shares

GASX

 25490K364

ISE-Revere Natural Gas Index

-300%

0.96%

0.95%

“We understand that market direction matters, so we strive to offer an alternative to static investment strategies while delivering exposure to the various markets in which traders have expressed high levels of interest,” said Sylvia Jablonski, Managing Director at Direxion. “We currently offer 3X leveraged bull funds for healthcare and natural gas stocks and both 3X bull and 3X bear funds for biotech stocks. These new bear funds will complement this existing suite of products to give traders a more nimble way to take advantage of short-term opportunities in these sectors.”

Like all leveraged ETFs, these Funds are intended only for traders with an in-depth understanding of the risks associated with seeking leveraged investment results, and who plan to actively monitor and manage their positions. There is no guarantee that the Funds will meet their objectives.

About Direxion

Direxion builds bold products for investors who want more than the status quo. Our index-based products deliver directional options, magnified exposure, and long-term, rules-based strategies. Founded in 1997, the company has approximately $9.2 billion in assets under management as of September 30, 2015. Direxion’s diverse suite of products helps investors navigate today’s ever-changing markets. For more information, please visit www.direxioninvestments.com.

You are viewing an abbreviated republication of ETF Daily News content. You can find full ETF Daily News articles on (www.etfdailynews.com)